FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagehl7.fhir.uv.xver-r3.r4b
Resource TypeValueSet
IdValueSet-R3-v3-EntityNamePartQualifier-for-R4B.json
FHIR VersionR4B
Sourcehttp://hl7.org/fhir/uv/xver-r3.r4b/0.1.0/ValueSet-R3-v3-EntityNamePartQualifier-for-R4B.html
URLhttp://hl7.org/fhir/uv/xver/ValueSet/R3-v3-EntityNamePartQualifier-for-R4B
Version0.1.0
Statusactive
Date2026-03-17T21:02:03.8104715+00:00
NameR3V3EntityNamePartQualifierForR4B
TitleCross-version ValueSet STU3.v3 Code System EntityNamePartQualifier for use in FHIR R4B
Realmuv
Authorityhl7
DescriptionThis cross-version ValueSet represents content from `http://hl7.org/fhir/ValueSet/v3-EntityNamePartQualifier|2016-11-11` for use in FHIR R4B.
PurposeThis value set is part of the cross-version definitions generated to enable use of the value set `http://hl7.org/fhir/ValueSet/v3-EntityNamePartQualifier|2016-11-11` as defined in FHIR STU3 in FHIR R4B. The source value set is bound to the following FHIR STU3 elements: * Across FHIR versions, the value set has been mapped as: * `http://hl7.org/fhir/ValueSet/v3-EntityNamePartQualifier|2016-11-11` * `http://terminology.hl7.org/ValueSet/v3-EntityNamePartQualifier|2018-08-12` Note that all concepts are included in this cross-version definition because no concepts have compatible representations Following are the generation technical comments: All concepts in the comparison are listed as identical. The source and target value sets have the same number of active concepts (23). FHIR ValueSet `http://hl7.org/fhir/ValueSet/v3-EntityNamePartQualifier|2016-11-11`, defined in FHIR STU3 does not have any mapping to FHIR R4B

Resources that use this resource

No resources found

Resources that this resource uses

CodeSystem
hl7.fhir.uv.xver-r2.r4b#0.1.0EntityNamePartQualifierv3-EntityNamePartQualifier

Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: ValueSet R3-v3-EntityNamePartQualifier-for-R4B

This value set expansion contains 29 concepts.

SystemVersionCodeDisplayDefinition
http://hl7.org/fhir/v3/EntityNamePartQualifier2016-11-11  ACacademic

Indicates that a prefix like "Dr." or a suffix like "M.D." or "Ph.D." is an academic title.

http://hl7.org/fhir/v3/EntityNamePartQualifier2016-11-11  ADadopted

The name the person was given at the time of adoption.

http://hl7.org/fhir/v3/EntityNamePartQualifier2016-11-11  BRbirth

A name that a person had shortly after being born. Usually for family names but may be used to mark given names at birth that may have changed later.

http://hl7.org/fhir/v3/EntityNamePartQualifier2016-11-11  CLcallme

A callme name is (usually a given name) that is preferred when a person is directly addressed.

http://hl7.org/fhir/v3/EntityNamePartQualifier2016-11-11  CONcontainer name

Description: This refers to the container if present in the medicinal product name.

                    EXAMPLES: 

                    
                       
                          For Optaflu suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, prepared in cell culture) (2007/2008 season): pre-filled syringe
http://hl7.org/fhir/v3/EntityNamePartQualifier2016-11-11  DEVdevice name

Description: This refers to the qualifiers in the name for devices and is at the moment mainly applicable to insulins and inhalation products.

                    EXAMPLES: 

                    
                       
                          For the medicinal product Actrapid FlexPen 100 IU/ml Solution for injection Subcutaneous use: FlexPen.
http://hl7.org/fhir/v3/EntityNamePartQualifier2016-11-11  FLAVFlavorName

Description: This refers to a flavor of the medicinal product if present in the medicinal product name.

                       Examples:
                    

                    
                       For 'CoughCure Linctus Orange Flavor', the flavor part is "Orange"
                       For 'Wonderdrug Syrup Cherry Flavor', the flavor part is "Cherry"
http://hl7.org/fhir/v3/EntityNamePartQualifier2016-11-11  FORMULFormulationPartName

Description: This refers to the formulation of the medicinal product if present in the medicinal product name.

                       Examples:
                    

                    
                       For 'SpecialMed Sugar Free Cough Syrup', the formulation name part is "Sugar Free"
                       For 'QuickCure Gluten-free Bulk Fibre', the formulation name part is "gluten-free"
http://hl7.org/fhir/v3/EntityNamePartQualifier2016-11-11  FRMform name

Description: This refers to the pharmaceutical form/ if present in the medicinal product name.

                    EXAMPLES: 

                    
                       
                          For Agenerase 50 mg soft capsules: Soft Capsules

                       
                       
                          For Ludiomil 25mg-Filmtabletten: Filmtabletten

                       
                       
                          For Optaflu suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, prepared in cell culture) (2007/2008 season): suspension for injection
http://hl7.org/fhir/v3/EntityNamePartQualifier2016-11-11  INinitial

Indicates that a name part is just an initial. Initials do not imply a trailing period since this would not work with non-Latin scripts. Initials may consist of more than one letter, e.g., "Ph." could stand for "Philippe" or "Th." for "Thomas".

http://hl7.org/fhir/v3/EntityNamePartQualifier2016-11-11  INVinvented name

Description: This refers to the product name without the trademark or the name of the marketing authorization holder or any other descriptor reflected in the product name and, if appropriate, whether it is intended e.g. for babies, children or adults.

                    EXAMPLES: 

                    
                       
                          Agenerase

                       
                       
                          Optaflu

                       
                       
                          Ludiomil
http://hl7.org/fhir/v3/EntityNamePartQualifier2016-11-11  LSLegal status

For organizations a suffix indicating the legal status, e.g., "Inc.", "Co.", "AG", "GmbH", "B.V." "S.A.", "Ltd." etc.

http://hl7.org/fhir/v3/EntityNamePartQualifier2016-11-11  NBnobility

In Europe and Asia, there are still people with nobility titles (aristocrats). German "von" is generally a nobility title, not a mere voorvoegsel. Others are "Earl of" or "His Majesty King of..." etc. Rarely used nowadays, but some systems do keep track of this.

http://hl7.org/fhir/v3/EntityNamePartQualifier2016-11-11  POPULTargetPopulationName

Description: This refers to the target population for the medicinal product if present in the medicinal product name

                       Examples:
                    

                    
                       For 'Broncho-Drug 3.5 mg-capsules for children', the target population part is "children"
                       For 'Adult Chesty Cough Syrup', the target population part is "adult"
http://hl7.org/fhir/v3/EntityNamePartQualifier2016-11-11  PRprofessional

Primarily in the British Imperial culture people tend to have an abbreviation of their professional organization as part of their credential suffices.

http://hl7.org/fhir/v3/EntityNamePartQualifier2016-11-11  PharmaceuticalEntityNamePartQualifiersPharmaceuticalEntityNamePartQualifiers

Description: Medication Name Parts are a means of specifying a range of acceptable "official" forms of the name of a product. They are used as patterns against which input name strings may be matched for automatic identification of products from input text reports. While they cover the concepts held under "doseForm" or "route" or "strength" the name parts are not the same and do not fit into a controlled vocabulary in the same way. By specifying up to 8 name parts a much larger range of possible names can be generated.

http://hl7.org/fhir/v3/EntityNamePartQualifier2016-11-11  SCIscientific name

Description: This refers to the product common or scientific name without the trademark or the name of the marketing authorization holder or any other descriptor reflected in the product name.

                    EXAMPLES: 

                    
                       
                          For Agenerase: N/A

                       
                       
                          For Optaflu: Influenza vaccine (surface antigen, inactivated, prepared in cell culture) (2007/2008 season)

                       
                       
                          For Ludiomil: N/A
http://hl7.org/fhir/v3/EntityNamePartQualifier2016-11-11  SPspouse

The name assumed from the partner in a marital relationship (hence the "SP"). Usually the spouse's family name. Note that no inference about gender can be made from the existence of spouse names.

http://hl7.org/fhir/v3/EntityNamePartQualifier2016-11-11  STRstrength name

Description: This refers to the strength if present in the medicinal product name. The use of decimal points should be accommodated if required.

                    EXAMPLES:

                    
                       
                          For Agenerase 50 mg soft capsules: 50mg

                       
                       
                          For Ludiomil 25mg-Filmtabletten: 25 mg

                       
                       
                          For Optaflu suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, prepared in cell culture) (2007/2008 season): N/A
http://hl7.org/fhir/v3/EntityNamePartQualifier2016-11-11  TIMETimeOrPeriodName

Description: This refers to a time or time period that may be specified in the text of the medicinal product name

                       Example:
                    

                    
                       For an influenza vaccine 'Drug-FLU season 2008/2009', the time/period part is "2008/2009 season"
http://hl7.org/fhir/v3/EntityNamePartQualifier2016-11-11  TITLEtitle

Indicates that a prefix or a suffix is a title that applies to the whole name, not just the adjacent name part.

http://hl7.org/fhir/v3/EntityNamePartQualifier2016-11-11  TMKtrademark name

Description: This refers to trademark/company element if present in the medicinal product name.

                    EXAMPLES: 

                    
                       
                          for Insulin Human Winthrop Comb 15: Winthrop
http://hl7.org/fhir/v3/EntityNamePartQualifier2016-11-11  USEintended use name

Description: This refers to the intended use if present in the medicinal product name without the trademark or the name of the marketing authorization holder or any other descriptor reflected in the product name.

                       Examples:
                    

                    
                       For 'Drug-BI Caplets - Heartburn Relief', the intended use part is: "Heartburn Relief"
                       For 'Medicine Honey Syrup for Soothing Coughs' the intended use part is "Soothing Coughs"
http://hl7.org/fhir/v3/EntityNamePartQualifier2016-11-11  VVvoorvoegsel

A Dutch "voorvoegsel" is something like "van" or "de" that might have indicated nobility in the past but no longer so. Similar prefixes exist in other languages such as Spanish, French or Portugese.

http://hl7.org/fhir/v3/EntityNamePartQualifier2016-11-11  _OrganizationNamePartQualifierOrganizationNamePartQualifier

OrganizationNamePartQualifier

http://hl7.org/fhir/v3/EntityNamePartQualifier2016-11-11  _PersonNamePartAffixTypesPersonNamePartAffixTypes

PersonNamePartAffixTypes

http://hl7.org/fhir/v3/EntityNamePartQualifier2016-11-11  _PersonNamePartChangeQualifierPersonNamePartChangeQualifier

PersonNamePartChangeQualifier

http://hl7.org/fhir/v3/EntityNamePartQualifier2016-11-11  _PersonNamePartMiscQualifierPersonNamePartMiscQualifier

PersonNamePartMiscQualifier

http://hl7.org/fhir/v3/EntityNamePartQualifier2016-11-11  _PersonNamePartQualifierPersonNamePartQualifier

PersonNamePartQualifier

Source1

{
  "resourceType": "ValueSet",
  "id": "R3-v3-EntityNamePartQualifier-for-R4B",
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
      "valueInteger": 0
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
      "valueCode": "fhir"
    },
    {
      "extension": [
        {
          "url": "packageId",
          "valueId": "hl7.fhir.uv.xver-r3.r4b"
        },
        {
          "url": "version",
          "valueString": "0.1.0"
        },
        {
          "url": "uri",
          "valueUri": "http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r3.r4b"
        }
      ],
      "url": "http://hl7.org/fhir/StructureDefinition/package-source"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
      "valueCode": "trial-use",
      "_valueCode": {
        "extension": [
          {
            "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
            "valueCanonical": "http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r3.r4b"
          }
        ]
      }
    }
  ],
  "url": "http://hl7.org/fhir/uv/xver/ValueSet/R3-v3-EntityNamePartQualifier-for-R4B",
  "version": "0.1.0",
  "name": "R3V3EntityNamePartQualifierForR4B",
  "title": "Cross-version ValueSet STU3.v3 Code System EntityNamePartQualifier for use in FHIR R4B",
  "status": "active",
  "experimental": false,
  "date": "2026-03-17T21:02:03.8104715+00:00",
  "publisher": "FHIR Infrastructure",
  "contact": [
    {
      "name": "FHIR Infrastructure",
      "telecom": [
        {
          "system": "url",
          "value": "http://www.hl7.org/Special/committees/fiwg"
        }
      ]
    }
  ],
  "description": "This cross-version ValueSet represents content from `http://hl7.org/fhir/ValueSet/v3-EntityNamePartQualifier|2016-11-11` for use in FHIR R4B.",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "http://unstats.un.org/unsd/methods/m49/m49.htm",
          "code": "001",
          "display": "World"
        }
      ]
    }
  ],
  "purpose": "This value set is part of the cross-version definitions generated to enable use of the\r\nvalue set `http://hl7.org/fhir/ValueSet/v3-EntityNamePartQualifier|2016-11-11` as defined in FHIR STU3\r\nin FHIR R4B.\r\n\r\nThe source value set is bound to the following FHIR STU3 elements:\r\n* \r\n\r\nAcross FHIR versions, the value set has been mapped as:\r\n* `http://hl7.org/fhir/ValueSet/v3-EntityNamePartQualifier|2016-11-11`\n* `http://terminology.hl7.org/ValueSet/v3-EntityNamePartQualifier|2018-08-12`\r\n\r\nNote that all concepts are included in this cross-version definition because no concepts have compatible representations\r\n\r\nFollowing are the generation technical comments:\r\nAll concepts in the comparison are listed as identical.\nThe source and target value sets have the same number of active concepts (23).\nFHIR ValueSet `http://hl7.org/fhir/ValueSet/v3-EntityNamePartQualifier|2016-11-11`, defined in FHIR STU3 does not have any mapping to FHIR R4B",
  "compose": {
    "include": [
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "concept": [
          {
            "code": "AC",
            "display": "academic"
          },
          {
            "code": "AD",
            "display": "adopted"
          },
          {
            "code": "BR",
            "display": "birth"
          },
          {
            "code": "CL",
            "display": "callme"
          },
          {
            "code": "CON",
            "display": "container name"
          },
          {
            "code": "DEV",
            "display": "device name"
          },
          {
            "code": "FLAV",
            "display": "FlavorName"
          },
          {
            "code": "FORMUL",
            "display": "FormulationPartName"
          },
          {
            "code": "FRM",
            "display": "form name"
          },
          {
            "code": "IN",
            "display": "initial"
          },
          {
            "code": "INV",
            "display": "invented name"
          },
          {
            "code": "LS",
            "display": "Legal status"
          },
          {
            "code": "NB",
            "display": "nobility"
          },
          {
            "code": "POPUL",
            "display": "TargetPopulationName"
          },
          {
            "code": "PR",
            "display": "professional"
          },
          {
            "code": "PharmaceuticalEntityNamePartQualifiers",
            "display": "PharmaceuticalEntityNamePartQualifiers"
          },
          {
            "code": "SCI",
            "display": "scientific name"
          },
          {
            "code": "SP",
            "display": "spouse"
          },
          {
            "code": "STR",
            "display": "strength name"
          },
          {
            "code": "TIME",
            "display": "TimeOrPeriodName"
          },
          {
            "code": "TITLE",
            "display": "title"
          },
          {
            "code": "TMK",
            "display": "trademark name"
          },
          {
            "code": "USE",
            "display": "intended use name"
          },
          {
            "code": "VV",
            "display": "voorvoegsel"
          },
          {
            "code": "_OrganizationNamePartQualifier",
            "display": "OrganizationNamePartQualifier"
          },
          {
            "code": "_PersonNamePartAffixTypes",
            "display": "PersonNamePartAffixTypes"
          },
          {
            "code": "_PersonNamePartChangeQualifier",
            "display": "PersonNamePartChangeQualifier"
          },
          {
            "code": "_PersonNamePartMiscQualifier",
            "display": "PersonNamePartMiscQualifier"
          },
          {
            "code": "_PersonNamePartQualifier",
            "display": "PersonNamePartQualifier"
          }
        ]
      }
    ]
  },
  "expansion": {
    "timestamp": "2026-03-17T21:02:03.8104715+00:00",
    "contains": [
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "code": "AC",
        "display": "academic"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "code": "AD",
        "display": "adopted"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "code": "BR",
        "display": "birth"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "code": "CL",
        "display": "callme"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "code": "CON",
        "display": "container name"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "code": "DEV",
        "display": "device name"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "code": "FLAV",
        "display": "FlavorName"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "code": "FORMUL",
        "display": "FormulationPartName"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "code": "FRM",
        "display": "form name"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "code": "IN",
        "display": "initial"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "code": "INV",
        "display": "invented name"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "code": "LS",
        "display": "Legal status"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "code": "NB",
        "display": "nobility"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "code": "POPUL",
        "display": "TargetPopulationName"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "code": "PR",
        "display": "professional"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "code": "PharmaceuticalEntityNamePartQualifiers",
        "display": "PharmaceuticalEntityNamePartQualifiers"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "code": "SCI",
        "display": "scientific name"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "code": "SP",
        "display": "spouse"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "code": "STR",
        "display": "strength name"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "code": "TIME",
        "display": "TimeOrPeriodName"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "code": "TITLE",
        "display": "title"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "code": "TMK",
        "display": "trademark name"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "code": "USE",
        "display": "intended use name"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "code": "VV",
        "display": "voorvoegsel"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "code": "_OrganizationNamePartQualifier",
        "display": "OrganizationNamePartQualifier"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "code": "_PersonNamePartAffixTypes",
        "display": "PersonNamePartAffixTypes"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "code": "_PersonNamePartChangeQualifier",
        "display": "PersonNamePartChangeQualifier"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "code": "_PersonNamePartMiscQualifier",
        "display": "PersonNamePartMiscQualifier"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifier",
        "version": "2016-11-11",
        "code": "_PersonNamePartQualifier",
        "display": "PersonNamePartQualifier"
      }
    ]
  }
}